Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Low oxygen areas help maintain and protect blood stem cells by using a simple sugar breakdown process for energy and managing their activity levels.

Myc activation reduces skin stem cells by affecting cell adhesion.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

Proper scalp care can improve hair health and delay ageing signs.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Altered lipid pathways in diabetic women may cause premature greying.

Epidermal growth factor helps stem cells heal wounds and regenerate hair follicles faster.

The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.

Hair follicle regeneration may slow tumor growth.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

Isoalantolactone promotes hair growth by activating specific cell pathways.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.